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Abstract
Protein secretion is essential for all bacteria in order to interact with their environment. Mycobacterium tuberculosis depends
on protein secretion to subvert host immune response mechanisms. Both the general secretion system (Sec) and the twin-
arginine translocation system (Tat) are functional in mycobacteria. Furthermore, a novel type of protein translocation system
named ESX has been identified. In the genome of M. tuberculosis five paralogous ESX regions (ESX-1 to ESX-5) have been
found. Several components of the ESX translocation apparatus have been identified over the last ten years. The ESX regions
are composed of a basic set of genes for the translocation machinery and the main substrate - a heterodimer. The best
studied of these heterodimers is EsxA (ESAT-6)/EsxB (CFP-10), which has been shown to be exported by ESX-1. EsxA/B is
heavily involved in virulence of M. tuberculosis. EsxG/H is exported by ESX-3 and seems to be involved in an essential iron-
uptake mechanism in M. tuberculosis. These findings make ESX-3 components high profile drug targets. Until now, reporter
systems for determination of ESX protein translocation have not been developed. In order to create such a reporter system,
a truncated b-lactamase (‘bla TEM-1) was fused to the N-terminus of EsxB, EsxG and EsxU, respectively. These constructs
have then been tested in a b-lactamase (BlaS) deletion strain of Mycobacterium smegmatis. M. smegmatis DblaS is highly
susceptible to ampicillin. An ampicillin resistant phenotype was conferred by translocation of Bla TEM-1-Esx fusion proteins
into the periplasm. BlaTEM-1-Esx fusion proteins were not found in the culture filtrate suggesting that plasma membrane
translocation and outer membrane translocation are two distinct steps in ESX secretion. Thus we have developed a
powerful tool to dissect the molecular mechanisms of ESX dependent protein translocation and to screen for novel
components of the ESX systems on a large scale.
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Introduction
Tuberculosis (TB) is a chronic, contagious disease caused by
several members of the Mycobacterium tuberculosis complex [1].
Although marginalized in America and central Europe, TB
remains an overwhelming burden on humanity. Approx. 2 billion
people - about a third of the world’s population - are carrier of the
pathogen, making TB a pandemic. Among these people, 5–10%
develop symptoms and become infectious themselves [2]. An
estimated 1.7 million infected people die from TB every year.
Subversion of the normal progression of the phagosomal
compartment into an active, bactericidal lysosomal compartment
is one of the key features of M. tuberculosis pathogenicity [3,4]. As
an additional resistance factor, mycobacteria possess a nearly
impenetrable cell envelope which protects the bacteria against
physical and chemical stress. This cell envelope also plays a crucial
role in intrinsic drug resistance in pathogenic mycobacteria, and is
one of the key features of persistence in latency [5]. The unique
mycobacterial cell envelope consists of a phospholipid bilayer
plasma membrane (PM), followed by a periplasmatic space (PP)
with two electron dense layers of unconfirmed identity [6]. The
inner of these layers, located proximal to the PM, appears to be
granular. The outer layer represents at least a part of the
peptidoglycan-arabinogalactan polymer [7]. Furthermore, the
bacteria posses an additional membrane called mycobacterial
outer membrane (MOM). The MOM is mainly composed of long
chain mycolic fatty acids (C60-C90) with free intercalating
glycolipids. It is covalently linked to the arabinogalactan-
peptidoglycan layer [8] and presents a veritable permeability
barrier. The outermost layer of the cell envelope is a capsule
composed of polysaccharides, proteins and small amounts of lipids
[9].
Protein secretion is essential for all bacteria in order to interact
with their environment. In monoderm bacteria export systems that
translocate proteins across the PM are sufficient. In diderm
bacteria such as the Gram-negatives or mycobacteria secreted
proteins have to overcome not only the PM but also the second
hydrophobic permeability barrier – the outer membrane. Both the
general secretion system (Sec) and the twin-arginine translocation
system (Tat) are functional in mycobacteria [10,11,12]. Interest-
ingly, it has been shown that mycobacteria possess an accessory,
non-essential SecA2 protein (compared to the housekeeping
SecA1) which is involved in the export of a specific subset of
proteins, e.g. the superoxide dismutase SodA [13]. Furthermore, a
high amount of small, highly immunogenic proteins lacking a
classical secretion signal peptide has been found in the culture
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100 amino acids (aa) and share a Trp-Xaa-Gly (WXG) motif [15].
The most prominent members of this protein family are the early
secreted antigen target, 6 kDa (ESAT-6, EsxA) and the culture
filtrate protein, 10 kDa (CFP-10, EsxB). Genes coding for WXG-
100 family proteins are found in the genome of all mycobacteria
and in a wide range of actinobacteria and low G+C content Gram-
positives [15]. Most of these WXG-100 proteins are predicted to
be exported by a novel type of protein translocation system in
mycobacteria often referred to as Type VII secretion system
(T7SS) [16] or more general as WXG-100 secretion systems (WSS)
[17,18]. In mycobacteria, where the T7SS have been discovered
first, the protein translocation machineries as well as the
corresponding genomic regions are commonly referred to as
ESAT-6 secretion systems (ESX). This term will be used
throughout this article. In M. tuberculosis five paralogous ESX
regions are annotated (ESX-1 to ESX-5). Several of these ESX
regions are also present in other members of the genus
Mycobacterium [19]. Outside the genus Mycobacterium, multiple
ESX regions have not been found so far. ESX gene clusters
typically also encode proteins of the mycobacterial specific
enigmatic PE and PPE families, named after their N-terminal
proline-glutamic acid (PE) and proline-proline-glutamic acid (PPE)
motifs [20].
The first ESX protein translocation system found in M.
tuberculosis (ESX-1) is required for full virulence [21]. Most genes
of ESX-1 are located in the region of difference-1 (RD-1), which is
prominently absent in the attenuated vaccine strain Mycobacterium
bovis BCG [22] and in Mycobacterium microti [23]. The exact
function of ESX-1 and its translocation substrates are not fully
understood yet. Among the reported functions are block of
phagosome maturation [24], suppression of proinflammatory
cytokine production [25] and disruption of membranes [26].
Furthermore, it has been shown that ESX-1 translocation plays an
essential role in mycobacterial DNA transfer in M. smegmatis [27].
Deletions in the ESX-1 gene cluster seem to increase the donor
function, whereas the same deletions abolish reception of
transferred DNA. Functional studies on the ESX-2 and ESX-4
systems have not been published so far. Whole genome studies
suggest that neither of these two systems is required for in vitro
growth or virulence [28,29]. Mycobacterium leprae is missing both the
ESX-2 and ESX-4 region from its minimal genome [19]. These
findings indicate a negligible function of these two ESX clusters.
ESX-3 is present in all mycobacterial genomes sequenced so far.
In M. tuberculosis and in M. smegmatis several studies have shown
that ESX-3 is involved in iron import [30,31]. Siegrist et al. found
evidence, that iron bound to secreted mycobactin can not be
utilized in ESX-3 deletion strains [32]. Although M. smegmatis
tolerates ESX-3 deletions quite well, the system seems to be
essential in M. tuberculosis since corresponding deletion mutants
could not be generated so far [28,31]. ESX-5 is the phylogenet-
ically youngest ESX region and restricted to slow growing,
pathogenic mycobacteria [19]. It has been show to be involved in
the secretion of a set of diverse PPE and PE_PGRS proteins [33].
ESX-5 has been linked to virulence in the fish pathogen M.
marinum [33,34] and was suggested to play a role in cell death in M.
tuberculosis related pathogenesis [35].
The M. tuberculosis ESX-1 system (and supposedly the ESX-5
system) is required for full virulence, therefore discovering and
characterizing its components is a focal point of mycobacterial
virulence research. However, there is a growing interest in the
essential ESX-3 system of M. tuberculosis [32,36,37,38,39] since its
components represent promising new targets for antimycobacterial
drugs. The absence of ESX-protein-translocation reporter limits
characterization of ESX systems, especially the identification of
components not encoded in the ESX region. In this study we
present such a reporter system for studying ESX protein
translocation.
Materials and Methods
Bacterial strains and growth conditions
Mycobacterium smegmatis SMR5, a derivative of M. smegmatis
mc
2155, carrying a non-restrictive rpsL mutation conferring
streptomycin resistance [40] was grown on Middlebrook 7H10
agar supplemented with 10% oleic acid albumin dextrose catalase
(OADC, Difco) and in liquid Middlebrook 7H9 supplemented
with 10% OADC and with Tween 80 (0.05%) to avoid clumping.
When appropriate, antibiotics were added at the following
concentrations: ampicillin, 120 mg/ml; streptomycin, 100 mg/ml;
hygromycin, 50 mg/ml; kanamycin, 50 mg/ml. The cells were
grown at 37uC. Strain designations were as follows: M. smegmatis
SMR5, M. smegmatis DblaS, a derivative of M. smegmatis SMR5 with
deleted blaS (MSMEG_2658) locus and M. smegmatis DblaS DeccD3,
a derivative of M. smegmatis DblaS with an additional deletion in
eccD3 (MSMEG_0623).
Plasmids
A series of heterologous fusion protein constructs were cloned
and expressed, using the epichromosomal, high copy number
shuttle vector pOLYG [41]. All fusion constructs consist of a
truncated form of the TEM-1 b-lactamase (‘Bla TEM-1),
originally identified in a clinical isolate of E. coli [42], and a
secreted protein from M. tuberculosis or M. smegmatis. The truncated
form of the b-lactamase (from here on referred to simply as
BlaTEM) lacks the N-terminal 19 amino acids (aa) comprising the
secretion signal peptide. It is no longer exported on its own. The
construction and schematic organization of the reporter constructs
is shown in figure 1. Unmarked targeted gene deletions were
generated using the mycobacterial suicide vector pMCS5
(MobiTec) with an additional hygromycin resistance cassette
[43] and a rpsL gene [40]. The deleted b-lactamase blaS from M.
smegmatis was complemented in trans using the integrative vector
pMV361-blaS, a derivative of pMV361 [44]. All plasmids used in
this study are listed in table S1 (supporting material).
Targeted gene replacements
Replacement of the targeted genes in this study - MSMEG_2658
(blaS) and MSMEG_0623 (eccD3) - were done by application of the
rpsL counter selection strategy [40]. Therefore, electrocompetent
streptomycin-resistant M. smegmatis SMR5 derivatives were
transformed with the suicide plasmids pMCS5-rpsL-hyg-DblaS
and pMCS5-rpsL-hyg-DeccD3. These vectors carry approx. 1 kbp
genomic regions adjacent to the targeted gene and an unmarked
deletion in the targeted gene. Transformants were grown on
hygromycin containing media and afterwards counter selected
using streptomycin. A point mutation in the rpsL gene coding for
the ribosomal protein S12 renders M. smegmatis SMR5 streptomy-
cin resistant. Thus, transformants integrating the knock out
plasmid that encodes the rpsL
+ locus by single cross-over
homologous recombination become sensitive to streptomycin
again. A second recombination event results in deletion of the
target gene (or revision to wild type) and restores the streptomycin
resistant and hygromycin sensitive phenotype. The deletion
mutant strains were confirmed by Southern blot analysis using
specific DNA probes (Fig. 2).
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Broth microdilution tests were performed in a microtiter plate in
a total volume of 100 ml. Bacterial strains were pre-cultured in
7H9 broth supplemented with Tween and OADC as described
above. Freshly grown cultures were diluted to an OD600 of 0.015,
and incubated in 7H9 broth in the presence of 2-fold serial
dilutions of ampicillin in the range between 400 mg/ml and
0.8 mg/ml. The minimal inhibitory concentration (MIC) is defined
as the drug concentration at which no visible growth is observed
by eye after an incubation time of 72 h, corresponding to 24
generations.
Preparation of cell extracts and Western blot analysis
M. smegmatis from 10 ml cultures were harvested and resus-
pended in phosphate-buffered saline (PBS). After a washing step,
the cells were disrupted and homogenized by sonication in an ice
bath (Elma, Transsonic T460H) for 1–2 hours. Culture filtrate was
concentrated using the Amicon Ultra-15 system (Millipore).
Proteins were separated by SDS-PAGE (12.5%) and analyzed by
Western blot. Antibodies against the b-lactamase were purchased
at Antikoerper-online.de.
Results
Targeted inactivation of blaS (MSMEG_2658)
M. smegmatis is naturally resistant to b-lactam antibiotics due to
the presence of an exported b-lactamase as demonstrated by
Flores et al. [45] and confirmed by us (Tab. 1). In order to use a b-
lactamase as a reporter in M. smegmatis, its native major b-
lactamase BlaS (MSMEG_2658) had to be disrupted first. The
genomic blaS was inactivated by targeted gene replacement using
the suicide vector pMCS5-rpsL-hyg-DblaS. A Southern blot analysis
confirming the deletion of blaS is shown in figure 2. The resulting
strain M. smegmatis DblaS was about 16 times more susceptible to
ampicillin than the wild-type strain (Tab. 1).
Reporter vectors
Deletion of its native b-lactamase renders M. smegmatis DblaS
highly susceptible to ampicillin. This is a prerequisite to use b-
lactamases as selectable reporters. We constructed and expressed
fusion constructs using the TEM-1 b-lactamase (Bla TEM-1) [42].
Compared to other b-lactamases, Bla TEM-1 has the significant
advantage of being compatible with both Sec and Tat signal
sequences, because it does not have to be folded prior to its
translocation as shown by McCann et al. [46]. In order to
investigate protein translocation in M. smegmatis, particularly ESX-
secretion, eight reporter vectors (pI-blaTEM to pVIII-blaTEM)
were constructed. These vectors contain promoters and parts of or
entire open reading frames (ORF) of Sec- and ESX-dependent
secreted proteins from M. tuberculosis (Fig. 1). In case of pVIII-
blaTEM the Esx part (EsxU) of the fusion protein is derived from
M. smegmatis. The ORF of each secreted protein was ligated in
frame with the ORF of blaTEM (a truncated version of bla TEM-1
without the 19 codons coding the secretion signal peptide). The
Figure 1. Schematic representation of the reporter fusion constructs. Shown are only the promoter regions, the truncated b-lactamase
(blaTEM) and the fused ORF with restriction endonuclease sites for cloning (not drawn to scale). Additional epitope tags for anti HA antibodies are
also annotated. The roman numbers on the left side correspond to the vector numbers. Along with blaTEM the vector pI-blaTEM contains the ORF
encoding the 40 aa N-terminal sec-secretion signal peptide of FbpB (Rv1886c). The vector pII-blaTEM originated from pI-blaTEM and contains the
additional 285 codons of the mature FbpB. In the plasmid pIII-blaTEM blaTEM is C-terminally fused to the ORF fbpB (325 codons). In pIV-blaTEM and
pV-blaTEM the ORF esxG (Rv0287, 96 codons) is either C- or N-terminally fused to blaTEM. pVI-blaTEM originates from pIV-blaTEM with esxG
substituted for esxB (Rv3874, 99 codons). In pVII-blaTEM and pVIII-blaTEM esxG is substituted for either esxUmt (Rv3445c, 104 codons)o resxUms
(MSMEG_1538, 102 codons). 0 stands for pOLYG-blaTEM expressing only the truncated version of Bla TEM-1 (267 aa) lacking the 19 aa secretion signal
peptide (BlaTEM). Note that the constructs 0 and I-III are expressed by the fbpB promoter (368 bp region upstream of the start codon) whereas the
esx constructs are under the control of the esxGmt promoter (500 bp region upstream of the start codon).
doi:10.1371/journal.pone.0035453.g001
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pOLYG [41]. The vectors were created in a modular design,
facilitating the construction of similar constructs as explained in
figure 1. pOLYG-blaTEM expressing only the truncated form of
Bla TEM-1 was constructed as a negative control. BlaTEM
without additional secretion signal is suspected to be localized in
the cytoplasm and therefore not to confer ampicillin resistance.
Expression of the reporter fusion constructs and
ampicillin susceptibility testing in M. smegmatis DblaS
Cell extract and culture supernatant was analyzed for the
presence of the reporter protein. Expression of the reporter
constructs at the protein level was shown by Western blot analysis
with an antibody specific for Bla TEM-1. BlaTEM-1 was readily
detected in the cell extracts (Fig. 3) but not in the concentrated
culture supernatant (data not shown). Ampicillin susceptibility of
the b-lactamase (BlaS) knock out strains with or without reporter
plasmids was determined by minimal inhibitory concentration
(MIC) assays. The results for each strain are shown in table 1. All
strains were also tested for susceptibility towards hygromycin
(resistance conferred by backbone of the pOLYG vectors) and
kanamycin (an unrelated antibiotic). The MIC determination
shows that all plasmid bearing strains were equally resistant to
hygromycin (MIC.500 mg/ml) compared to the not transformed
parental strains which were equally susceptible to hygromycin
(MIC 20 mg/ml). This suggests a similar reporter plasmid copy
number in all strains. All strains – parental and reporter – were
found to be equally sensitive to kanamycin (MIC 12.5 mg/ml).
Kanamycin binds to the 30S subunit of bacterial ribosomes - an
intracellular target (data not shown). Due to the results of the
kanamycin resistance determination it is unlikely that the
introduced genetic alteration generally heightened the membrane
permeability for antibiotics.
The MIC data show that the ampicillin sensitive M. smegmatis
DblaS strain can be complemented with pMV361-blaS, thereby
restoring its natural resistance. M. smegmatis DblaS transformed
with pOLYG-blaTEM (a vector expressing a truncated version of
Bla TEM-1 without secretion signal sequence) remains susceptible
to ampicillin. Insertion of the Sec signal sequence from the
fibronectin binding protein B (Antigen 85B, Rv1886c) FbpB (pI-
blaTEM) confers ampicillin resistance (MIC 100–200 mg/ml). The
resistance is even higher when in addition to the signal peptide the
entire FbpB is fused to BlaTEM. The expression cassette: Sec-
BlaTEM-FbpB is expressed by pII-blaTEM (MIC 200–400 mg/
ml). FbpB-BlaTEM is expressed by pIII-blaTEM and also confers
high level ampicillin resistance (MIC 200–400 mg/ml). These
results coincided with results from McCann et al. [46].
Figure 2. Strategy for targeted generation of mutants and Southern blot analysis. (A) Schematic drawing of the blaS (MSMEG_2658)
genomic region of the wild-type and the knock out strain (not drawn to scale). Southern blot analysis confirms the deletion of blaS from the genome
of M. smegmatis. Genomic DNA of M. smegmatis was digested with restriction endonuclease MluI. A DIG labeled PCR fragment from one of the
flanking regions was used as a probe. The wild-type band (wt) was calculated to be 3.39 kbp. The 39 single cross over (sco) bands correspond to
lengths of 9.451 kbp and 2.483 kbp, respectively. The knock out strain (D) corresponds to a length of 2.483 kbp. (B) Schematic drawing of the eccD3
(MSMEG_0623) genomic region of the wild-type and the knock out strain (not drawn to scale). Southern blot analysis confirms the deletion of eccD3
from the genome of M. smegmatis DblaS. Genomic DNA was digested with restriction endonuclease Tth111I. The wild-type band (wt) was calculated
to be 4.309 kbp. The 59 single cross over (sco) bands correspond to lengths of 10.316 kbp and 4.309 kbp, respectively. The knock out strain (D)
corresponds to a length of 5.680 kbp.
doi:10.1371/journal.pone.0035453.g002
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annotated ESX systems of M. smegmatis (ESX-1, ESX-3 and ESX-
4) we created a new reporter system by fusing BlaTEM with a M.
tuberculosis protein supposed to be specific for each system. EsxB
(CFP-10, Rv3874) located in the ESX-1 cluster, EsxG (Rv0287)
located in the ESX-3 cluster and EsxU (Rv3445c) located in the
ESX-4 cluster were chosen. The vector pIV-blaTEM expressed
fusion protein BlaTEM-EsxG and the vector pV-blaTEM the
reverse constellation, i.e. EsxG-BlaTEM (Fig. 1). pVI-blaTEM
expressed BlaTEM-EsxB and pVII-blaTEM expressed BlaTEM-
EsxU. Both pIV-blaTEM [BlaTEM-EsxG] and pVI-blaTEM
[BlaTEM-EsxB] conferred ampicillin resistance in M. smegmatis
DblaS. Transformation of the vector pV-blaTEM could not confer
ampicillin resistance despite expression of the fusion protein
(Fig. 3B). Vector pVII-blaTEM was also unable to confer
ampicillin resistance. We hypothesized that the secretion signal
of EsxU from M. tuberculosis (EsxUMt) was not recognized by M.
smegmatis ESX-4. Therefore we exchanged EsxUMt with EsxU
Table 1. Ampicillin MIC of M. smegmatis DblaS strains with or without reporter plasmid.
strain plasmid reporter MIC (mg/mL) amp
M. smegmatis SMR5 none none 200–400
M. smegmatis DblaS none none 12.5–25
M. smegmatis DblaS-blaS pMV361-blaS (integrated) BlaS 200–400
M. smegmatis DblaS pOLYG-blaTEM BlaTEM 12.5–25
M. smegmatis DblaS pI-blaTEM
a Sec-BlaTEM 100–200
M. smegmatis DblaS pII-blaTEM
a Sec-BlaTEM-‘FbpB 200–400
M. smegmatis DblaS pIII-blaTEM
a FbpB-BlaTEM 200–400
M. smegmatis DblaS pIV-blaTEM
b BlaTEM-EsxG .400
M. smegmatis DblaS pV-blaTEM
b* EsxG-BlaTEM 12.5–25
M. smegmatis DblaS pVI-blaTEM
c BlaTEM-EsxB 100–200
M. smegmatis DblaS pVII-blaTEM
d BlaTEM-EsxUMt 12.5–25
M. smegmatis DblaS pVIII-blaTEM
d BlaTEM-EsxUMs 12.5–25
Predicted export systems:




*Export signal supposedly not recognized since internal.
doi:10.1371/journal.pone.0035453.t001
Figure 3. Protein expression of BlaTEM reporter constructs shown by Western blot analysis. Fusion-proteins expressed from the nine
reporter vectors (pOLYG-blaTEM (0) and pI-blaTEM to pVIII-blaTEM) were separated using SDS-PAGE (12.5% Tris-HCl gels) and blotted onto PVDF
membrane. The membrane was incubated with an antibody against the b-lactamase TEM-1. (A) Protein expression of pOLYG-blaTEM (calculated mass
31.8 kDa) and the three Sec dependent FbpB b-lactamase fusion-constructs (pI-blaTEM, pII-blaTEM and pIII-blaTEM). Their masses were calculated to
be 31.5 kDa, 33.3 kDa, 61.5 kDa and 62.2 kDa, respectively. The apparent molecular weight corresponds to the mass of a mature protein without
secretion signal sequence. (B) Expression of b-lactamase fusion products associated with one of the three ESX protein translocation systems in M.
smegmatis DblaS: EsxG (ESX-3), EsxB (ESX-1) and EsxU (ESX-4) expressed from pIV-blaTEM (40.7 kDa), pVI-blaTEM (41.7 kDa), pVII-blaTEM (42.3 kDa)
and pVIII-blaTEM (42.3 kDa). Although the C-terminally fused ‘‘EsxG-BlaTEM’’ (from pV-blaTEM; 41.5 kDa) and both ESX-4 associated N-terminally
fused ‘‘BlaTEM-EsxU’’ are translated, no ampicillin resistant phenotype could be observed in the MIC assays. As a positve control (+) lysate from E. coli
expressing Bla TEM-1 from pGEM-T easy (Promega) was used. The negative control (2) consists of lysate resulting from M. smegmatis DblaS with
pOLYG.
doi:10.1371/journal.pone.0035453.g003
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reporter vector pVIII-blaTEM. Nevertheless, pVIII-blaTEM also
was not able to confer ampicillin resistance in M. smegmatis DblaS
despite expression of the fusion protein (Fig. 3B).
Targeted inactivation of EccD3 (MSMEG_0623) and
ampicillin susceptibility testing in M. smegmatis DblaS
DeccD3
EccD3 encodes the supposed pore protein of the ESX-3 secretion
system [19]. Using M. smegmatis DblaS as parental strain, a deletion
in eccD3 was generated resulting in strain M. smegmatis DblaS
DeccD3. Inactivation of EccD3 did not affect susceptibility to
ampicillin as compared to the parental strain (Tab. 2). A Southern
blot confirming the deletion of eccD3 region is shown in figure 2.
The strain deficient in EccD3 (M. smegmatis DblaS DeccD3) was
transformed with the reporter vectors. Ampicillin susceptibility of
M. smegmatis DblaS DeccD3 double knock out strain was determined
in the same fashion as in the single knock out strain M. smegmatis
DblaS. The results are shown in table 2. As expected, the strain
expressing the ESX-3 related construct BlaTEM-EsxG was no
longer able to confer ampicillin resistance thus confirming the
specificity of the reporter construct. Recombinants expressing
reporter constructs of the Sec- or ESX-1 pathway were not
affected by the deletion of EccD3 with respect to the ampicillin
resistance phenotype. These results were confirmed by plating the
strains on 7H10 Amp (120 mg/ml) and are shown in figure 4.
Discussion
In monoderm Gram-positives, protein translocation processes
are export processes. In these bacteria, protein export equals
protein secretion, since the bacteria do not possess an outer
membrane [17]. The majority of protein secretion in monoderm
Gram-positives is conducted by the general secretion system (Sec)
and the twin arginine transport system (Tat) [38]. In some Gram-
positives, protein translocation can also be performed by
WXG100-family secretion systems (WSS). WSS are especially
found in all diderm Gram-positives, where the Sec, Tat and
supposedly WSS are export systems. In mycobacteria, where WSS
were described first, the terms type VII secretion system (T7SS)
and ESAT-6 secretion systems (ESX) are most commonly used.
The substrate translocated by the ESX system is ultimately found
in the culture supernatant and thus extracellular. Actual proof that
ESX are responsible for one step secretion similar to the Gram-
negative type III and type IV secretion systems has yet to be given.
A new bioinformatics approach suggests EccB1 and/or EccE1 as
MOM channels for ESX-1 substrates [47]. However it is very well
possible that an independent, hypothetical translocation machin-
ery is located in the mycobacterial outer membrane handling the
second translocation step for all the exported proteins destined for
secretion into the extracellular milieu. Much progress has been
made in elucidating the mycobacterial protein translocation,
however there are still many puzzle pieces missing.
In 2005, Flores et al. identified the major secreted b-lactamases
of M. tuberculosis (BlaC, Rv2068c) and of M. smegmatis (BlaS,
MSMEG_2658) [48]. The b-lactamase knock out strains were
Table 2. Ampicillin MIC of M. smegmatis DblaS DeccD3 strains with or without reporter plasmid.
strain plasmid reporter MIC (mg/mL) amp
M. smegmatis DblaS DeccD3 pOLYG-blaTEM BlaTEM 12.5–25
M. smegmatis DblaS DeccD3 pI-blaTEM
a Sec-BlaTEM 100–200
M. smegmatis DblaS DeccD3 pII-blaTEM
a Sec-BlaTEM-‘FbpB 200–400
M. smegmatis DblaS DeccD3 pIII-blaTEM
a FbpB-BlaTEM 200–400
M. smegmatis DblaS DeccD3 pIV-blaTEM
b BlaTEM-EsxG 12.5–25
M. smegmatis DblaS DeccD3 pVI-blaTEM
c BlaTEM-EsxB 100–200
Predicted export systems:




Figure 4. Growth of M. smegmatis strains on an agar plate
containing ampicillin. Freshly grown cultures were diluted to an
OD600 of 0.015. 1 ml of each strain was streaked in a separate sector on a
Middlebrook 7H10 plate containing ampicillin [120 mg/ml]. The plate
was incubated for 3 days at 37uC. The parental strain in the sectors 1–5
is M. smegmatis DblaS. The parental strain in sectors 6–8 is M. smegmatis
DblaS DeccD3. Additional roman numbers correspond to the reporter
vector in each strain (cf. tables 1+2). Reporter constructs: (2): none; 0:
BlaTEM; II: Sec-BlaTEM-‘FbpB; IV: BlaTEM-EsxG; and VI: BlaTEM-EsxB.
Note: The reporter construct BlaTEM-EsxG from pIV-blaTEM (sector 7) is
no longer able to confer ampicillin resistance when a key component of
ESX-3 (EccD3) is deleted. In contrast, constructs specific for Sec (sector 6)
and ESX-1 (sector 8) dependent translocation still confer an ampicillin
resistance phenotype.
doi:10.1371/journal.pone.0035453.g004
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M. smegmatis, respectively. The Tat translocated BlaC [10] and the
Sec translocated b-lactamase TEM-1 (Bla TEM-1) [46] - originally
identified in a clinical isolate of E. coli [42] - were used as reporter
in these strains. Bla TEM-1 fulfils all criteria for an export-reporter
enzyme. It is small and can easily be fused to other proteins. Bla
TEM-1 is inactive in the cytoplasm and can confer ampicillin
resistance in a M. smegmatis DblaS strain when exported [46]. For
these reasons we used a truncated version of Bla TEM-1 (BlaTEM)
– lacking secretion signal peptide – as a reporter in our BlaS knock
out strain (M. smegmatis DblaS). The minimal inhibitory concen-
tration (MIC) of ampicillin of M. smegmatis DblaS was about 16-fold
lower compared to the wild-type strain. This ampicillin susceptible
M. smegmatis DblaS became the parental strain for all other strains.
A first series of reporter constructs was generated by C-terminal
fusion of the N-terminally truncated Bla TEM-1 (lacking its native
secretion signal peptide) to several variants of the fibronectin
binding protein B (FbpB; antigen 85b of M. tuberculosis). FbpB is
secreted via the Sec pathway. Ampicillin resistance was conferred
due to expression and export of the heterologous BlaTEM
proteins. M. smegmatis DblaS expressing BlaTEM without a signal
peptide remained sensitive to ampicillin. These results coincided
with results from McCann et al. [46].
We established an ESX-specific reporter system by fusing
blaTEM N-terminally and in frame with genes encoding proteins
associated with the ESX translocation systems such as esxB (cfp-10,
Rv3874), esxG (Rv0287) and esxU (Rv3445c). The reporter
constructs with their suspected translocation machineries are
drawn in figure 5. The constructs BlaTEM-EsxB and BlaTEM-
EsxG conferred ampicillin resistance in M. smegmatis DblaS. EsxB
possesses a C-terminal secretion signal sequence [49]. Here we
showed that EsxG bears an analogous sequence which is suspected
to be specific for ESX-3 protein translocation. The N-terminal
fusion-construct EsxG-BlaTEM did not confer ampicillin resis-
tance. Together, these results suggest that the translocation signal
sequence has to be located at the C-terminus. Since we could not
detect the BlaTEM fusion products in the supernatant using the b-
lactamase antibody in Western blots (data not shown), we suspect,
that the reporters are exported and remain in the PP. These
findings indicate that ESX-dependent secretion comprises two
discrete steps, translocation across the PM and subsequently
translocation across the MOM. Dissection of these steps is possible
since translocation into the PP confers a selectable phenotype. The
subsequent translocation step of the reporter constructs may be
disturbed because of the heterologous expression, the size of the
fusion protein, its folding, or absence of an interaction partner.
Interestingly both EsxB and EsxG from M. tuberculosis seem to be
translocated by M. smegmatis without co-expression of the proposed
heterodimer partner proteins EsxAMt and EsxHMt. Eventually
EsxBMt and EsxGMt can bind to EsxAMs and EsxHMs and
translocate together. Alternatively, translocation does not require a
dimerization step as long as a C-terminal secretion signal is
attached to the translocation substrate.
To test specificity of the ESX system for translocation reporters
we created an ESX-3 deletion strain (eccD3, MSMEG_0623)o fM.
smegmatis DblaS. BlaTEM-EsxG was no longer able to confer
ampicillin resistance in M. smegmatis DblaS DeccD3, indicating that
EsxG is specifically translocated by ESX-3. In contrast Sec- and
Figure 5. Schematic drawing of the cell envelope and the known protein export systems of M. smegmatis. Displayed is a simplified
model of a cell envelope (without outer capsular layer) as suggested by cryo-electron tomography images [6,9]. PM stands for the phospholipid
bilayer plasma membrane. The periplasmatic space (PP) contains two electron dense layers of unconfirmed identity L1 and L2. The additional
membrane is the mycobacterial outer membrane (MOM). The general secretion system (Sec) is colored brown as is one of its substrate: FbpB. FbpB
contains a cleavable Sec signal peptide represented as an attached oval. The twin arginine translocation pathway (Tat) is represented in green. One of
its substrate is the mayor secreted b-lactamase BlaS containing a cleavable Tat signal peptide. BlaS is missing in the DblaS knock out strain. The ESX
protein translocation systems 1, 3 and 4 of M. smegmatis are drawn together with their suggested heterodimeric substrates: EsxA/B, EsxH/G and EsxT/
U. EsxB, EsxG and EsxU posses a C-terminal secretion signal represented as a small attached circle. All reporter constructs used in this study are
schematically represented and lettered with the corresponding roman number (cf. Fig. 1). The b-lactamase BlaTEM fusion partner is represented as a
red box (Bla). Solid arrows indicate a functional translocation event, dotted arrow indicate that translocation function has not been demonstrated so
far. The grey oval with the question mark drawn in the MOM represents a yet unknown translocation system for crossing the second permeability
barrier.
doi:10.1371/journal.pone.0035453.g005
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phenotype. This indicates that other translocation systems are not
affected by EccD3 deletion.
BlaTEM-EsxU was unable to confer ampicillin resistance even
though it was expressed. To test if merely the homology between
the secretion signal of EsxUMt (Rv3445c) and EsxUMs
(MSMEG_1538) was too low, the two genes were exchanged in
the BlaTEM constructs. Nonetheless BlaTEM-EsxUMs was not
able to confer ampicillin resistance in M. smegmatis DblaS. EsxU was
never found in culture filtrates of M. tuberculosis [50] and also does
not seem to be exported in our experiments. Therefore, we
speculate that ESX-4 in both M. tuberculosis and in M. smegmatis is
either not transcribed or not functional as a translocation system
anymore. The absence of the genes coding for an AAA+ ATPase
(EccA) and the transmembrane protein (EccE) in the ESX-4
operon supports the latter hypothesis. Also missing are genes
coding for PE and PPE proteins.
In conclusion we have established a reporter system for
functional investigation of ESX protein translocation. The
reporter system works with both ESX-1 and ESX-3 substrates.
Since ESX-3 is essential in M. tuberculosis but not in M. smegmatis,
we have now an excellent format for studying components of
ESX-3 dependent protein translocation. The reporter system
facilitates identification and confirmation of novel components of
ESX protein translocation systems for plasma membrane transport
by a genetic approach. Furthermore, we have for the first time a
tool for high throughput screening of drugs interfering with crucial
components of the ESX system (ESX-1 or ESX-3), which could
give us a new edge in fighting drug resistant M. tuberculosis strains as
proposed by Feltcher et al. [38].
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